FDA Inspection 1259422 — Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
The FDA completed an inspection of Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) on January 14, 2025 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)